However, unlike ZMC1, COTI-2 showed no effects on intracellular zinc levels in HNSCC-mutant TP53 cells, suggesting that COTI-2 is not a traditional zinc metallochaperone [14]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.